.jpg)
Opko, Entera share ownership of first oral GLP-1/glucagon agonist set to enter clinic
Opko Health and Entera Bio have formalized their partnership as the biotechs prepare to take the first oral dual agonist GLP-1/glucagon peptide into the clinic.
Opko Health and Entera Bio have formalized their partnership as the biotechs prepare to take the first oral dual agonist GLP-1/glucagon peptide into the clinic.
